Showing results (1-10 of 707) with videos related to
Sort By:
Pageof 71
Cancer|April 10, 2004
Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignanciesAmit Panwalkar, Srdan Verstovsek, Francis GilesCancer|February 11, 2004
Mammalian target of rapamycin inhibition as therapy for hematologic malignanciesAmit Panwalkar, Srdan Verstovsek, Francis J GilesSeminars in Thrombosis and Hemostasis|July 1, 2006
Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disordersAlfonso Quintás-Cardama, Hagop M Kantarjian, Francis Giles, et al.Leukemia & Lymphoma|April 11, 2015
Novel therapies for myelofibrosisBrady L Stein, Francisco Cervantes, Francis Giles, et al.Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
Highlights in polycythemia vera from the 2016 EHA congressSrdan VerstovsekPostgraduate Medicine|February 9, 2013
Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosisSrdan VerstovsekHematology. American Society of Hematology. Education Program|December 17, 2009
Therapeutic potential of JAK2 inhibitorsSrdan VerstovsekAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Therapeutic advances in myeloproliferative neoplasms: the role of new-small molecule inhibitorsSrdan VerstovsekAnnals of Hematology|February 14, 2023
How I manage anemia related to myelofibrosis and its treatment regimensSrdan VerstovsekClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosisSrdan VerstovsekPageof 71